Cemiplimab

1: Rodio M, Tettamanzi M, Trignano E, Rampazzo S, Serra PL, Grieco F, Boccaletti R, Veneziani Santonio F, Fadda GM, Sanna F, Di Mario D, Rubino C. Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma of the Scalp: An Algorithm for Reconstruction and Treatment. J Clin Med. 2024 Mar 10;13(6):1581. doi: 10.3390/jcm13061581. PMID: 38541808; PMCID: PMC10971407.

2: Mahashabde R, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, Li C. Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non-Small-Cell Lung Cancer and Synchronous Brain Metastases. JCO Oncol Pract. 2023 Nov;19(11):1009-1019. doi: 10.1200/OP.23.00042. Epub 2023 Sep 20. PMID: 37729600.

3: Zhao B, Qi H, Wu J, Ma W. Cemiplimab Plus Chemotherapy Could Be a First-Line Option for Advanced and Metastatic NSCLC: Results From the Phase 3 EMPOWER-Lung 3 Part 2 Trial. J Thorac Oncol. 2023 Jul;18(7):e72-e73. doi: 10.1016/j.jtho.2023.04.001. PMID: 37348996.

4: Trignano E, Tettamanzi M, Rampazzo S, Trignano C, Boccaletti R, Fadda GM, Sanna F, Bussu F, Cossu A, Rubino C. Squamous cell carcinoma of the scalp: a combination of different therapeutic strategies. Case Reports Plast Surg Hand Surg. 2023 May 12;10(1):2210670. doi: 10.1080/23320885.2023.2210670. PMID: 37197191; PMCID: PMC10184606.

5: Zhang C, Zhou W, Zhang D, Ma S, Wang X, Jia W, Guan X, Qian K. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta- analysis. Open Med (Wars). 2023 Feb 14;18(1):20220574. doi: 10.1515/med-2022-0574. PMID: 36820064; PMCID: PMC9938645.

6: Grounds K, Emmanuel O. Inoperable poorly differentiated SCC to vertex of scalp progressing into sagittal sinus treated with palliative Cemiplimab. Clin Case Rep. 2022 Aug 24;10(8):e05679. doi: 10.1002/ccr3.5679. PMID: 36034608; PMCID: PMC9400036.

7: Ghosh A, Harish Bindiganavile S, Bhat N, Lee AG. A Case of Miller Fisher Syndrome Due to the Use of Cemiplimab. J Neuroophthalmol. 2021 Sep 1;41(3):e343-e345. doi: 10.1097/WNO.0000000000001062. PMID: 32868575.